Insert title here

Abstract

Review Article


Year: 2022 |Volume: 3 | Issue: 04 |Pages: 14-20


A critical review on Glaucoma and its management in Ayurveda

About Author

Niras Anjali1

1Associate Professor, Dept of Shalakyatantra, Yashwantrao Chavan Ayurved Medical College, Aurangabad.

Correspondence Address:

Dr.Anjali Niras Associate Professor, Dept of Shalakyatantra Yashwantrao Chavan Ayurved Medical College, Aurangabad. Email : dranjalign@gmail.com

Date of Acceptance: 2022-04-06

Date of Publication:2022-05-20

Article-ID:IJIM_157_05_22 https://ijim.co.in

Source of Support: Nil

Conflict of Interest: Nil


How To Cite This Article: Niras Anjali. A critical review on Glaucoma and its management in Ayurveda. Int J Ind Med 2022;3(3):14-20 http://doi.org/10.55552/IJIM.2022.3402


Abstract


Shalakya tantra is a branch of Ashtanga Ayurveda that treats Chakshu, Nasa, Shirah, Kantha, Mukha and Karna diseases. Glaucoma is an optic nerve neurodegenerative disease which mainly affects people in their forties and fifties caused by a group of ocular conditions which lead to damage of optic nerve with loss of visual function. Glaucoma is the world's second-leading cause of irreversible blindness, and India's third-leading cause. This ailment is connected to Adhimantha in Ayurveda. Adhimantha is a Sarvagata netraroga according to Acharya Sushruta and Vagbhatta. It is identical to Glaucoma in terms of etiopathogenesis, clinical characteristics, consequences, and therapeutic concepts. Prana-Vyana vayu, and Alochaka pitta are the Doshas and Rasa-Raktha-Mamsa- are the Dushyas involved in the pathophysiology. This results in the Optic Nerve Head alterations and field abnormalities that might lead to blindness. Ayurvedic management prevents eye ageing, rejuvenates the eyes, and enhances eye function. Medicines used topically have a greater bioavailability than drugs administered orally. Ayurvedic medicines and therapies keep the body in check, illness as well as prevent blindness.


Keywords: Adhimanta, Glaucoma, Shalakya, Eye disease, Blindness

Print

Published

20/05/2022

Issue: 04

Volume: 3 (2022): Month - 05

Insert title here